| Nutraplus India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524764 |
NSE Symbol : - |
P/E(TTM) : - |
|
ISIN Demat : INE230G01020 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : -1.54 |
Market Cap(₹Cr) : 7.16 |
Face Value(₹) : 5.00 |
| Particulars | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Total Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Total Expenditure | 0.12 | 0.01 | 0.08 | 0.01 | 3.72 | 0.01 |
| PBIDT | -0.12 | -0.01 | -0.08 | -0.01 | -3.70 | -0.01 |
| Interest | 0.03 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
| PBDT | -0.15 | -0.01 | -0.11 | -0.01 | -3.70 | -0.01 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -0.15 | -0.01 | -0.11 | -0.01 | -3.70 | -0.01 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.15 | -0.01 | -0.11 | -0.01 | -3.70 | -0.01 |
| EPS (Unit Curr.) | -0.04 | 0.00 | -0.03 | 0.00 | -1.09 | 0.00 |
| EPS (Adj) (Unit Curr.) | -0.04 | 0.00 | -0.03 | 0.00 | -1.09 | 0.00 |
| Calculated EPS (Unit Curr.) | -0.04 | 0.00 | -0.03 | 0.00 | -1.09 | 0.00 |
| Calculated EPS (Adj) (Unit Curr.) | -0.04 | 0.00 | -0.03 | 0.00 | -1.09 | 0.00 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.17 | -0.01 | -0.13 | -0.01 | -4.35 | -0.01 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.17 | -0.01 | -0.13 | -0.01 | -4.35 | -0.01 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PATM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |